YEOM; Young Il

Patent Applications and Registrations

Patent applications and USPTO patent grants for YEOM; Young Il.The latest application filed is for "method for preventing or treating cancer using syt11 inhibitor".

Company Profile

0.15.13

YEOM; Young Il - Daejeon KR
Yeom; Young Il - Dong-gu KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Preventing Or Treating Cancer Using Syt11 Inhibitor App 20210361694 - CHEONG; Jae Ho ; et al.	2021-11-25
Pharmaceutical composition for treating cancer Grant 9,217,149 - Won , et al. December 22, 2	2015-12-22
CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer Grant 9,075,066 - Lee , et al. July 7, 2	2015-07-07
G protein coupled receptor protein and use thereof Grant 9,034,327 - Chung , et al. May 19, 2	2015-05-19
Pharmaceutical Composition For Treating Cancer App 20140371300 - Won; Misun ; et al.	2014-12-18
Pharmaceutical composition for treating cancer Grant 8,846,630 - Won , et al. September 30, 2	2014-09-30
Composition containing inhibitors of the expression or activity of SH3RF2 for preventing or treating cancer Grant 8,809,295 - Park , et al. August 19, 2	2014-08-19
Method for diagnosis/prognosis of cancers using an epigenetic marker consisting of a specific single CpG site in TTP promoter and treatment of cancers by regulating its epigenetic status Grant 8,703,419 - Yeom , et al. April 22, 2	2014-04-22
Use of FLJ25416 gene Grant 8,486,905 - Won , et al. July 16, 2	2013-07-16
Pharmaceutical Composition For Treating Cancer App 20130028957 - Won; Misun ; et al.	2013-01-31
Composition Containing Inhibitors of the Expression or Activity of SH3RF2 for Preventing or Treating Cancer App 20120321635 - Park; Kyung Chan ; et al.	2012-12-20
Characterization of ESM-1 as a tumor associated marker of colorectal cancer Grant 8,283,129 - Song , et al. October 9, 2	2012-10-09
Method For Diagnosis/prognosis Of Cancers Using An Epigenetic Marker Consisting Of A Specific Single Cpg Site In Ttp Promoter And Treatment Of Cancers By Regulating Its Epigenetic Status App 20120251499 - Yeom; Young Il ; et al.	2012-10-04
Novel G Protein Coupled Receptor Protein And Use Thereof App 20120141488 - Chung; Kyung Sook ; et al.	2012-06-07
Diagnostic Kit Of Colon Cancer Using Colon Cancer Related Marker And Diagnostic Method Thereof App 20110251097 - Song; Eun Young ; et al.	2011-10-13
Novel Use Of Flj25416 Gene App 20110008370 - Won; Misun ; et al.	2011-01-13
Characterization of ESM-1 as a Tumor Associated Marker of Colorectal Cancer App 20100248244 - Song; Eun Young ; et al.	2010-09-30
Ppia Marker For Diagnosis Of Liver Cancer And Antibody, And Screening Method Of Compounds Useful For Inhibiting Liver Cancer App 20100203510 - Kim; Dae-Ghon ; et al.	2010-08-12
Preparation of monoclonal antibody to N-myc downstream regulated gene 2 and determination of NDRG2 using protein chip Grant 7,718,780 - Song , et al. May 18, 2	2010-05-18
MAC-2BP as a Marker for the Diagnosis of Gastric Cancer App 20090130694 - Lee; Hee Gu ; et al.	2009-05-21
Preparation of monoclonal antibody to N-myc downstream regulated gene 2 and determination of NDRG2 using protein chip App 20070128194 - Song; Eun Young ; et al.	2007-06-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.